The Schall Law Firm is seeking investors who purchased Eos Energy Enterprises securities between November 5, 2025 and February 26, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements regarding production levels, capacity utilization, and battery downtime, failing to meet previous guidance and resulting in investor losses.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Eos Energy Enterprises, Soleno Therapeutics, Nektar Therapeutics, and Driven Brands Holdings Inc. The lawsuits allege that these companies made false or misleading statements regarding their operations, financial reporting, and business prospects. Lead plaintiff deadlines range from May 5-8, 2026.

Rosen Law Firm is notifying investors in Eos Energy Enterprises, Inc. (NASDAQ: EOSE) of a securities class action lawsuit and a May 5, 2026 lead plaintiff deadline. The lawsuit alleges that Eos Energy made false statements regarding production capacity, battery line downtime, quality targets, and guidance accuracy, resulting in investor damages when the true details became public.

A class action lawsuit has been filed against Eos Energy Enterprises, Inc. (NASDAQ: EOSE) alleging securities fraud. The complaint claims the company made materially false statements and failed to disclose production delays, excessive battery line downtime, quality control issues with automated bipolar production, and inadequate systems for ensuring accurate guidance. The class period covers November 5, 2025 to February 26, 2026, with a lead plaintiff deadline of May 5, 2026.

Kirby McInerney LLP reminds Eos Energy Enterprises investors of the May 5, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges the company failed to achieve production guidance, experienced excessive battery line downtime, and made inaccurate public disclosures. Eos Energy reported a $970 million net loss for 2025 with revenue falling short of guidance, causing shares to decline 39.4% on February 26, 2026.

A class action lawsuit has been filed against Eos Energy Enterprises (NASDAQ: EOSE) for allegedly making materially false and misleading statements regarding production capacity, battery line downtime, and quality targets during the period of November 5, 2025 to February 26, 2026. Investors have until May 5, 2026 to apply as lead plaintiff.

A securities class action lawsuit has been filed against Eos Energy Enterprises (EOSE) for allegedly making false statements about its scaling ability and failing to disclose manufacturing problems. The company's stock plunged 39% on February 26, 2026, after revealing a 25% revenue miss for FY 2025 and admitting to battery line downtime issues that exceeded industry norms. Investors are urged to submit losses by May 5, 2026.

Rosen Law Firm has filed a securities class action lawsuit against Eos Energy Enterprises, Inc. (NASDAQ: EOSE) on behalf of investors who purchased securities between November 5, 2025 and February 26, 2026. The lawsuit alleges that defendants made false and misleading statements regarding production growth, battery production line downtime, automation delays, and insufficient systems to ensure accurate guidance disclosure. The deadline to apply as lead plaintiff is May 5, 2026.

Rosen Law Firm is soliciting investors with losses exceeding $100,000 in Super Micro Computer, Eos Energy Enterprises, and Soleno Therapeutics to join securities class action lawsuits. The Super Micro case alleges the company made false statements about its business while concealing that a significant portion of server sales violated U.S. export control laws and that material weaknesses existed in compliance controls. The lead plaintiff deadline is May 26, 2026.

Rosen Law Firm is encouraging investors with losses exceeding $100K in Eos Energy Enterprises, Soleno Therapeutics, and New Era Energy & Digital to join securities class action lawsuits. The lawsuits allege that defendants made false statements regarding production capabilities, operational performance, and business prospects. The lead plaintiff deadline is May 5, 2026.

Rosen Law Firm is encouraging investors with losses exceeding $100,000 to join securities class action lawsuits against Soleno Therapeutics, Eos Energy Enterprises, and New Era Energy & Digital. The primary focus is on Soleno, which faces allegations of concealing safety concerns related to its DCCR drug candidate for Prader-Willi syndrome, including fluid retention issues and materially lower commercial viability. The lead plaintiff deadline is May 5, 2026.

Eos Energy Enterprises faces a securities fraud class action lawsuit after reporting 2025 revenue of $114.2 million, significantly below its $150-160 million guidance. The company attributed the shortfall to battery line downtime exceeding industry norms and production quality delays. The stock fell 39.4% on the announcement. Investors have until May 5, 2026 to file a lead plaintiff motion.